Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: A network meta-analysis.

Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis:... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Multiple Sclerosis and Related Disorders Pubmed

Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: A network meta-analysis.

Xu, Xinghua; Chi, Sumin; Wang, Qun; Li, Chengxin; Xu, Bainan; Zhang, Jun; Chen, Xiaolei
Multiple Sclerosis and Related Disorders , Volume 25: 7 – Dec 18, 2018
Download PDF
Loading next page...
 
/lp/pubmed/efficacy-and-safety-of-monoclonal-antibody-therapies-for-relapsing-GARtHv3Xab

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
2211-0348
DOI
10.1016/j.msard.2018.08.026
pmid
30195200

Abstract

Journal

Multiple Sclerosis and Related Disorders – Pubmed

Published: Dec 18, 2018

There are no references for this article.